Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Igor Akushevich is active.

Publication


Featured researches published by Igor Akushevich.


Scientifica | 2012

Effect of the APOE Polymorphism and Age Trajectories of Physiological Variables on Mortality: Application of Genetic Stochastic Process Model of Aging

Konstantin G. Arbeev; Svetlana V. Ukraintseva; Alexander M. Kulminski; Igor Akushevich; Lyubov S. Arbeeva; Culminskaya; Dequing Wu; Anatoli I. Yashin

We evaluated effects of the APOE polymorphism (carriers versus noncarriers of the e4 allele) and age trajectories of total cholesterol (CH) and diastolic blood pressure (DBP) on mortality risk in the Framingham Heart Study (original cohort). We found that long-lived carriers and noncarriers have different average age trajectories and long-lived individuals have consistently higher levels and less steep declines at old ages compared to short-lived individuals. We applied the stochastic process model of aging aimed at joint analyses of genetic and nongenetic subsamples of longitudinal data and estimated different aging-related characteristics for carriers and noncarriers which otherwise cannot be evaluated from data. We found that such characteristics differ in carriers and noncarriers: (1) carriers have better adaptive capacity than noncarriers in case of CH, whereas for DBP the opposite situation is observed; (2) mean allostatic trajectories are higher in carriers and they differ from “optimal” trajectories minimizing mortality risk; (3) noncarriers have lower baseline mortality rates at younger ages but they increase faster than those for carriers resulting in intersection at the oldest ages. Such observations strongly indicate the presence of a genetic component in respective aging-related mechanisms. Such differences may contribute to patterns of allele- and sex-specific mortality rates.


Journal of the American Geriatrics Society | 2008

Body Mass Index and Nine-Year Mortality in Disabled and Nondisabled Older U.S. Individuals

Alexander M. Kulminski; Konstantin G. Arbeev; Irina Kulminskaya; Svetlana V. Ukraintseva; Kenneth C. Land; Igor Akushevich; Anatoli I. Yashin

OBJECTIVES: To investigate the relationship between body mass index (BMI) and 9‐year mortality in older (≥65) Americans with and without disability.


Journal of the American Geriatrics Society | 2007

Cumulative Index of Health Deficiencies as a Characteristic of Long Life

Alexander M. Kulminski; Svetlana V. Ukraintseva; Igor Akushevich; Konstantin G. Arbeev; Anatoli I. Yashin

OBJECTIVES: To describe the accumulation of aging‐associated health disorders using a cumulative measure known as a frailty index (FI) and to evaluate its ability to differentiate long‐ and short‐life phenotypes as well as the FIs connection to aging‐associated processes in older people.


Journal of Physics G | 1994

Radiative effects in deep inelastic scattering of polarized leptons by polarized light nuclei

Igor Akushevich; N. Shumeiko

Principal contributions to QED radiative effects in deep inelastic scattering (DIS) of polarized leptons by polarized targets (H,D,3He) are investigated both on the Born level and taking into account radiative corrections (RC). Scattering in the case of transverse polarized targets is also considered. All quantities are presented in terms of covariant variables. Exact results are obtained for low-order corrections. Detailed numerical analysis under the conditions of forthcoming polarization experiments is carried out. Two points of view on calculation of RC to experimental data are discussed in detail. The results of a computer run in the regime of data-processing iteration procedure are presented.


Journal of the National Cancer Institute | 2015

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.

Mathias Worni; Igor Akushevich; Rachel A. Greenup; Deba Sarma; Marc D. Ryser; Evan R. Myers; E. Shelley Hwang

BACKGROUND Impact of contemporary treatment of pre-invasive breast cancer (ductal carcinoma in situ [DCIS]) on long-term outcomes remains poorly defined. We aimed to evaluate national treatment trends for DCIS and to determine their impact on disease-specific (DSS) and overall survival (OS). METHODS The Surveillance, Epidemiology, and End Results (SEER) registry was queried for patients diagnosed with DCIS from 1991 to 2010. Treatment pattern trends were analyzed using Cochran-Armitage trend test. Survival analyses were performed using inverse probability weights (IPW)-adjusted competing risk analyses for DSS and Cox proportional hazard regression for OS. All tests performed were two-sided. RESULTS One hundred twenty-one thousand and eighty DCIS patients were identified. The greatest proportion of patients was treated with lumpectomy and radiation therapy (43.0%), followed by lumpectomy alone (26.5%) and unilateral (23.8%) or bilateral mastectomy (4.5%) with significant shifts over time. The rate of sentinel lymph node biopsy increased from 9.7% to 67.1% for mastectomy and from 1.4% to 17.8% for lumpectomy. Compared with mastectomy, OS was higher for lumpectomy with radiation (hazard ratio [HR] = 0.79, 95% confidence interval [CI] = 0.76 to 0.83, P < .001) and lower for lumpectomy alone (HR = 1.17, 95% CI = 1.13 to 1.23, P < .001). IPW-adjusted ten-year DSS was highest in lumpectomy with XRT (98.9%), followed by mastectomy (98.5%), and lumpectomy alone (98.4%). CONCLUSIONS We identified substantial shifts in treatment patterns for DCIS from 1991 to 2010. When outcomes between locoregional treatment options were compared, we observed greater differences in OS than DSS, likely reflecting both a prevailing patient selection bias as well as clinically negligible differences in breast cancer outcomes between groups.


Journal of the American Geriatrics Society | 2012

Age Patterns of Incidence of Geriatric Disease in the U.S. Elderly Population:: Medicare-Based Analysis

Igor Akushevich; Julia Kravchenko; Svetlana V. Ukraintseva; Konstantin G. Arbeev; Anatoliy I. Yashin

To use the Medicare Files of Service Use (MFSU) to evaluate patterns in the incidence of aging‐related diseases in the U.S. elderly population.


Biogerontology | 2007

Health decline, aging and mortality: how are they related?

Anatoli I. Yashin; Konstantin G. Arbeev; Aliaksandr Kulminski; Igor Akushevich; Lucy Akushevich; Svetlana V. Ukraintseva

The deterioration of human health with age is manifested in changes of thousands of physiological and biological variables. The contribution of some of such changes to the mortality risk may be small and cannot be reliably detected by existing statistical methods. A cumulative index of health/well-being disorders, which counts changes in observed variables on the way of losing health, may be an appropriate way to take the effects of such variables into account. In this paper we investigate regularities of the aging-related changes in human health/well-being/survival status described by such an index using the new version of the quadratic hazard model of human aging and mortality. We found that the shape and the location of the mortality risk, considered as a function of the introduced health-related index, changes with age reflecting the decline in stress resistance and the age-dependence of the “optimal” health/well-being status. Comparison of these results with findings from early studies using the Cox’s-like model of risk function indicates that the results are likely to describe regularities of deterioration in human health during the aging process.


Age and Ageing | 2013

Time trends of incidence of age-associated diseases in the US elderly population: medicare-based analysis

Igor Akushevich; Julia Kravchenko; Svetlana V. Ukraintseva; Konstantin G. Arbeev; Anatoly I. Yashin

OBJECTIVES time trends of age-adjusted incidence rates of 19 ageing-related diseases were evaluated for 1992-2005 period with the National Long Term Care Survey and the Surveillance, Epidemiology and End RESULTS Registry data both linked to Medicare data (NLTCS-Medicare and SEER-Medicare, respectively). METHODS the rates were calculated using individual medical histories (34,077 individuals from NLTCS-Medicare and 199,418 from SEER-Medicare) reconstructed using information on diagnoses coded in Medicare data, dates of medical services/procedures and Medicare enrolment/disenrolment. RESULTS increases of incidence rates were dramatic for renal disease [the average annual percent change (APC) is 8.56%, 95% CI = 7.62, 9.50%], goiter (APC = 6.67%, 95% CI = 5, 90, 7, 44%), melanoma (APC = 6.15%, 95% CI = 4.31, 8.02%) and Alzheimers disease (APC = 3.96%, 95% CI = 2.67, 5.26%), and less prominent for diabetes and lung cancer. Decreases of incidence rates were remarkable for angina pectoris (APC = -6.17%, 95% CI = -6.96, -5.38%); chronic obstructive pulmonary disease (APC = -5.14%, 95% CI = -6.78,-3.47%), and ulcer (APC = -5.82%, 95% CI = -6.77,-4.86%) and less dramatic for carcinomas of colon and prostate, stroke, hip fracture and asthma. Incidence rates of female breast carcinoma, myocardial infarction, Parkinsons disease and rheumatoid arthritis were almost stable. For most diseases, an excellent agreement was observed for incidence rates between NLTCS-Medicare and SEER-Medicare. A sensitivity analysis proved the stability of the evaluated time trends. CONCLUSION time trends of the incidence of diseases common in the US elderly population were evaluated. The results show dramatic increase in incidence rates of melanoma, goiter, chronic renal and Alzheimers disease in 1992-2005. Besides specifying widely recognised time trends on age-associated diseases, new information was obtained for trends of asthma, ulcer and goiter among the older adults in the USA.


Aging Cell | 2011

Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan

Alexander M. Kulminski; Irina Culminskaya; Svetlana V. Ukraintseva; Konstantin G. Arbeev; Liubov S. Arbeeva; Deqing Wu; Igor Akushevich; Kenneth C. Land; Anatoli I. Yashin

Progress in unraveling the genetic origins of healthy aging is tempered, in part, by a lack of replication of effects, which is often considered a signature of false‐positive findings. We convincingly demonstrate that the lack of genetic effects on an aging‐related trait can be because of trade‐offs in the gene action. We focus on the well‐studied apolipoprotein E (APOE) e2/3/4 polymorphism and on lifespan and ages at onset of cardiovascular diseases (CVD) and cancer, using data on 3924 participants of the Framingham Heart Study Offspring cohort. Kaplan–Meier estimates show that the e4 allele carriers live shorter lives than the non‐e4 allele carriers (log rank = 0.016). The adverse effect was attributed to the poor survival of the e4 homozygotes, whereas the effect of the common e3/4 genotype was insignificant. The e3/4 genotype, however, was antagonistically associated with onsets of those diseases predisposing to an earlier onset of CVD and a later onset of cancer compared to the non‐e4 allele genotypes. This trade‐off explains the lack of a significant effect of the e3/4 genotype on survival; adjustment for it in the Cox regression model makes the detrimental effect of the e4 allele highly significant (P = 0.002). This trade‐off is likely caused by the lipid‐metabolism‐related (for CVD) and nonrelated (for cancer) mechanisms. An evolutionary rationale suggests that genetic trade‐offs should not be an exception in studies of aging‐related traits. Deeper insights into biological mechanisms mediating gene action are critical for understanding the genetic regulation of a healthy lifespan and for personalizing medical care.


Biogerontology | 2010

Exceptional survivors have lower age trajectories of blood glucose: lessons from longitudinal data

Anatoli I. Yashin; Konstantin G. Arbeev; Igor Akushevich; Svetlana V. Ukraintseva; Alexander M. Kulminski; Liubov S. Arbeeva; Irina Culminskaya

Exceptional survival results from complicated interplay between genetic and environmental factors. The effects of these factors on survival are mediated by the biological and physiological variables, which affect mortality risk. In this paper, we evaluated the role of blood glucose (BG) in exceptional survival using the Framingham heart study data for the main (FHS) and offspring (FHSO) cohorts. We found that: (1) the average cross-sectional age patterns of BG change over time; (2) the values of BG level among the longest lived individuals in this study differ for different sub-cohorts; (3) the longitudinal age patterns of BG differ from those of cross-sectional ones. We investigated mechanisms forming average age trajectories of BG in the FHS cohort. We found that the two curves: one, characterizing the average effects of allostatic adaptation, and another, minimizing mortality risk for any given age, play the central role in this process. We found that the average BG age trajectories for exceptional survivors are closer to the curve minimizing mortality risk than those of individuals having shorter life spans. We concluded that individuals whose age trajectories of BG are located around the curve minimizing chances of premature death at each given age have highest chances of reaching exceptional longevity.

Collaboration


Dive into the Igor Akushevich's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge